The Summary
In a crossover pilot trial, 33 patients with Parkinson's disease received one month of bright light therapy (10,000 lx) and one month of dim light therapy (200 lx). Both therapies improved subjective sleep quality. However, bright light therapy was more effective at reducing daytime sleepiness and was linked to visual network improvements in the brain. Conversely, dim light therapy better eased anxiety and enhanced default mode network activity. While between-treatment brain scan differences were not significant, the results suggest that light intensity can be tailored to specific symptoms.
Why this is interesting
This research challenges the 'more is always better' approach to light therapy. Traditionally, high-intensity light is seen as the gold standard for circadian issues. This study shows that gentler, dim light may actually be superior for calming anxiety and altering brain connectivity associated with rest. For patients with Parkinson's disease, this means light therapy doesn't have to be a one-size-fits-all treatment; clinicians might soon prescribe specific light dosages to target either debilitating daytime fatigue or anxiety, offering a non-pharmacological way to boost quality of life.